Stoke Therapeutics, Inc. <STOK.O>: JPMorgan resumes coverage with overweight rating; target price $40
STOK•Related News
Eldorado Gold Corporation <EGO.N>: Jefferies initiates coverage with buy rating; target price $50
EGO•
Ross Stores Inc <ROST.O>: Barclays raises target price to $298 from $260
ROST•
Comfort Systems USA, Inc. <FIX.N>: D.A. Davidson initiates coverage with Buy rating; target price $2,100
FIX•
China pledges timely fiscal support to bolster growth
SPY•
GLOBAL MARKETS-Asia shares downbeat for week as bond yields, oil stay high
SPY•